Project Grant R01DK138974

Award Date 5/1/24
Completion Date 4/30/29
Dollars Obligated $1.3M
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
St. Louis, MO 63110, USA
Similar Awards
This $1,331,148 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research) supports research at Yale University to investigate mechanisms of islet cell compensation for B-cell mass deficiency in diabetes. The key research objectives are to: Determine the signaling mechanisms underlying B-cell compensation in a novel mouse model of B-cell replication deficiency. Elucidate the mechanisms...
This $437,156 Project Grant was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant will fund a 5-year study to investigate the mechanisms by which cystic fibrosis (CF) impacts pancreatic islet cell function and insulin release, leading to the development of CF-related diabetes (CFRD). The research will be conducted by The Governors of the University of...
This $126,480 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) supports research at the University of California, Davis to investigate the role of the signaling protein 14-3-3-z in regulating communication between alpha and beta cells in the pancreatic islet. The goal is to shed light on new mechanisms underlying islet cell crosstalk and its impact on islet function, which could open new avenues for understanding and treating type 2...
This Project Grant award, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports a 5-year research and career development program for the Principal Investigator (PI), Dr. Samantha Adamson, to become an independent physician-scientist in diabetes research. The $153,266 award will fund Dr. Adamson's research at Washington University to define the mechanisms of...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $1,948,235 to Duke University to conduct research on alpha-to-beta cell communication and its role in insulin secretion and glucose homeostasis. The project will utilize preclinical studies in human islets as well as clinical studies in human subjects to investigate how alpha...
This Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $152,879 to the University of Utah to investigate the role of primary cilia signaling in adipocyte differentiation and adipose tissue expansion. The project aims to: 1) define the necessity and sufficiency of compartmentalized cAMP signaling within primary cilia to induce adipogenesis, and 2) identify G...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) provides $267,310 to Purdue University from August 2024 to February 2028 to support research on the role of G protein-coupled estrogen receptor (GPER) signaling in maintaining beta cell identity and function. The research aims to define the relationship between impaired store-operated calcium entry (SOCE) and GPER expression/localization, and the role of GPER in beta cell...
This Cooperative Agreement award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $1,201,988 to Yale University to develop advanced pancreatic-immune organoid models for studying type 1 diabetes (T1D) subtypes and therapeutic responses. The goal is to identify B cell intrinsic features that determine T1D progression and responses to therapies. In Phase 1, the...
This $698,646 federal Project Grant was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant aims to study the functional and disease relevance of distinct pancreatic beta-cell subtypes, with a focus on understanding their epigenetic regulation and relationship to type 2 diabetes (T2D). The research will use novel single-cell epigenomic tools, conditional...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $208,428 to The Regents of the University of California, San Francisco (UCSF) to enhance the safety and efficacy of stem cell-derived islet transplantation for treating type 1 diabetes. The key focus is on utilizing CRISPR-mediated genome engineering to improve islet cell engraftment,...

PARACRINE REGULATION OF ISLET CELL FUNCTION BY PRIMARY CILIA - PROJECT SUMMARY/ABSTRACT THE PRIMARY CILIUM PLAYS CRITICAL ROLES IN CELLULAR SIGNALING WHICH WITHIN THE PANCREATIC ISLETS ARE ESSENTIAL FOR THE PROPER REGULATION OF HORMONE SECRETION AND BLOOD GLUCOSE CONTROL. IN BOTH HUMANS AND RODENT MODELS, DIABETES MANIFESTS FROM MISREGULATED ISLET CELL SECRETORY FUNCTION DUE TO ALTERED CROSSTALK AND COORDINATION AMONG THE KEY ENDOCRINE CELLS, BUT THE ETIOLOGY OF ISLET CELL PARACRINE DYSREGULATION IN DIABETES IS UNKNOWN. OUR RECENT STUDIES REVEAL THAT PRIMARY CILIA ARE REQUIRED FOR THE MAINTENANCE OF ISLET FUNCTION BY ALLOWING ISLET CELLS TO SENSE AND RESPOND TO EACH OTHER'S ACTIVITY STATUS AS COMMUNICATED BY HORMONAL CUES. BASED ON THESE FINDINGS, WE HYPOTHESIZE THAT PRIMARY CILIA PROMOTE ISLET CELL COORDINATION BY MEDIATING PARACRINE HORMONE SIGNALING VIA THE MAJOR A- AND B-CELL HORMONES. TO THESE THIS HYPOTHESIS, WE WILL USE ISLET CELL- SPECIFIC PRIMARY CILIA DELETION MOUSE MODELS TO DELINEATE THE MECHANISMS BY WHICH A/B-CELL CILIA REGULATE PARACRINE HORMONE RELEASE AND ACTION ON TARGET CELLS. AIM 1 WILL DETERMINE WHETHER PRIMARY CILIA MEDIATE A-CELL INTRA-ISLET SIGNALING VIA GLUCAGON AND GLP-1. AIM 2 WILL DETERMINE WHETHER PRIMARY CILIA MEDIATE B-CELL INTRA-ISLET SIGNALING VIA INSULIN AND SEROTONIN. IN BOTH AIMS, WE WILL EMPLOY ORTHOGONAL IMAGING AND BIOCHEMICAL APPROACHES IN PRIMARY ISLETS TO DELINEATE A PHYSIOLOGIC ROLE FOR PRIMARY CILIA IN ISLET FUNCTION. A DETAILED UNDERSTANDING OF ISLET CELL INTER- REGULATION BY PRIMARY CILIA COULD SUPPORT THE DEVELOPMENT OF NOVEL THERAPIES TO TREAT OR PREVENT ISLET FAILURE IN DIABETES.

Posted 4/19/24, 12:00 AM